News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,118 Results
Type
Article (87509)
Company Profile (714)
Press Release (778884)
Multimedia
Podcasts (181)
Webinars (28)
Section
Business (233055)
Career Advice (4138)
Deals (39835)
Drug Delivery (147)
Drug Development (91236)
Employer Resources (205)
FDA (18288)
Job Trends (17427)
News (397379)
Policy (39917)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (1)
Accelerated approval (32)
Adcomms (28)
Allergies (146)
Alliances (56931)
ALS (175)
Alzheimer's disease (1766)
Antibody-drug conjugate (ADC) (327)
Approvals (18529)
Artificial intelligence (550)
Autoimmune disease (156)
Automation (39)
Bankruptcy (403)
Best Places to Work (12604)
BIOSECURE Act (22)
Biosimilars (195)
Biotechnology (443)
Bladder cancer (158)
Brain cancer (58)
Breast cancer (643)
Cancer (4845)
Cardiovascular disease (407)
Career advice (3562)
Career pathing (40)
CAR-T (295)
CDC (52)
Celiac Disease (2)
Cell therapy (774)
Cervical cancer (37)
Clinical research (76799)
Collaboration (1719)
Company closure (4)
Compensation (1157)
Complete response letters (56)
COVID-19 (2976)
CRISPR (94)
C-suite (845)
Cystic fibrosis (150)
Data (6222)
Decentralized trials (2)
Denatured (74)
Depression (138)
Diabetes (505)
Diagnostics (7212)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (257)
Drug pricing (203)
Drug shortages (32)
Duchenne muscular dystrophy (236)
Earnings (100013)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (134411)
Executive appointments (973)
FDA (21401)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1475)
Gene editing (204)
Generative AI (47)
Gene therapy (627)
GLP-1 (1076)
Government (5392)
Grass and pollen (6)
Guidances (383)
Healthcare (20897)
HIV (58)
Huntington's disease (48)
IgA nephropathy (83)
Immunology and inflammation (260)
Immuno-oncology (58)
Indications (110)
Infectious disease (3246)
Inflammatory bowel disease (199)
Inflation Reduction Act (17)
Influenza (117)
Intellectual property (249)
Interviews (814)
IPO (17940)
IRA (55)
Job creations (5200)
Job search strategy (2865)
JPM (67)
Kidney cancer (16)
Labor market (96)
Layoffs (630)
Leadership (34)
Legal (10132)
Liver cancer (97)
Longevity (14)
Lung cancer (658)
Lymphoma (377)
Machine learning (42)
Management (65)
Manufacturing (812)
MASH (167)
Medical device (14987)
Medtech (15040)
Mergers & acquisitions (22932)
Metabolic disorders (1326)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (91)
Neuroscience (3021)
Neurotech (1)
NextGen: Class of 2026 (7675)
Non-profit (5109)
Now hiring (68)
Obesity (633)
Opinion (319)
Ovarian cancer (168)
Pain (200)
Pancreatic cancer (228)
Parkinson's disease (283)
Partnered (33)
Patents (500)
Patient recruitment (489)
Peanut (60)
People (66733)
Pharmaceutical (134)
Pharmacy benefit managers (32)
Phase 1 (23730)
Phase 2 (33362)
Phase 3 (25109)
Pipeline (5269)
Policy (310)
Postmarket research (3550)
Preclinical (10656)
Press Release (72)
Prostate cancer (239)
Psychedelics (54)
Radiopharmaceuticals (297)
Rare diseases (854)
Real estate (7435)
Recruiting (81)
Regulatory (28901)
Reports (68)
Research institute (2718)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (79)
Schizophrenia (154)
Series A (246)
Series B (191)
Service/supplier (27)
Sickle cell disease (98)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (48)
Startups (4331)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (86)
The Weekly (105)
Vaccines (1104)
Venture capital (97)
Weight loss (425)
Women's health (96)
Worklife (21)
Date
Today (151)
Last 7 days (589)
Last 30 days (2114)
Last 365 days (30136)
2026 (3405)
2025 (30373)
2024 (37022)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (90)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (51419)
Australia (9041)
California (11398)
Canada (3294)
China (1109)
Colorado (484)
Connecticut (480)
Delaware (339)
Europe (117841)
Florida (1689)
Georgia (362)
Hawaii (4)
Idaho (68)
Illinois (921)
India (67)
Indiana (530)
Iowa (23)
Japan (429)
Kansas (133)
Kentucky (39)
Louisiana (28)
Maine (77)
Maryland (1413)
Massachusetts (8262)
Michigan (336)
Minnesota (647)
Mississippi (5)
Missouri (130)
Montana (33)
Nebraska (29)
Nevada (124)
New Hampshire (81)
New Jersey (3025)
New Mexico (28)
New York (2990)
North Carolina (1559)
North Dakota (8)
Northern California (5524)
Ohio (337)
Oklahoma (22)
Oregon (53)
Pennsylvania (2290)
Puerto Rico (24)
Rhode Island (49)
South America (1664)
South Carolina (66)
South Dakota (1)
Southern California (4396)
Tennessee (174)
Texas (1761)
United States (40699)
Utah (335)
Vermont (1)
Virginia (270)
Washington D.C. (84)
Washington State (944)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
867,118 Results for "biospace inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
NextGen
BioSpace
’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics,
BioSpace
’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.
January 7, 2026
·
2 min read
·
Annalee Armstrong
Job Trends
Hiring Plans Show Promise for Biopharma Job Seekers:
BioSpace
Report
More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new
BioSpace
employment outlook report. Areas in demand this year include research and development and clinical. Organizations are also prioritizing artificial intelligence hires.
January 29, 2026
·
5 min read
·
Angela Gabriel
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Job Trends
Employers Warm Up to Remote Workers Again:
BioSpace
Report
Biopharmas are less focused on local job candidates and are more open to recruiting regardless of location, according to the new
BioSpace
employment outlook report. Even employers who prefer to hire locally would consider remote hires for some roles.
February 5, 2026
·
5 min read
·
Angela Gabriel
Business
ICYMI: 5
BioSpace
Features From 2025 That Stand the Test of Time
Of all the stories we published this year, these deep dives by
BioSpace
editors stand out as relevant re-reads going into the New Year.
December 23, 2025
·
6 min read
·
Jef Akst
Layoff Tracker
Seres Will Cut 30% of Staff While Shifting Focus to Emerging Programs
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
February 12, 2026
·
53 min read
·
BioSpace Editorial Staff
Job Trends
BioSpace
2026 Best Places to Work Spotlights Most Desirable Workplaces
BioSpace
has named 50 life sciences companies to its 2026 Best Places to Work list. AbbVie, Amneal Pharmaceuticals and BridgeBio executives share what makes their organizations special.
November 4, 2025
·
7 min read
·
Angela Gabriel
Employer Resources
Report: 2026 Employment Outlook
BioSpace
’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
January 28, 2026
·
1 min read
·
BioSpace Insights
Job Trends
Almost 1/3 Eyeing Job Options Outside US,
BioSpace
Finds
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a
BioSpace
LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.
October 30, 2025
·
4 min read
·
Angela Gabriel
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
1 of 86,712
Next
